We are delighted to welcome you to the Institute of Molecular Medicine & Experimental Immunology.

The Institute of Molecular Medicine and Experimental Immunology (IMMEI) was founded in 2002. It is located in the Biomedical center II on the Medical faculty on the Venusberg-Campus of the Friedrich-Wilhelms-Universität Bonn. The scientific mission of the IMMEI is to understand the molecular and cellular mechanisms controlling immune responses in tissues, resulting either in inflammation, immunity or immune tolerance. Comprehensive knowledge of the physiological regulation of immune responses is essential to understand the defense against infections and tumors and to avoid autoimmunity. Ultimately, we aim to develop new therapeutic strategies to modulate local immune responses to benefit patients. More information...


September 23, 2022

EMDS 2022: Myeloid Cells in Immunoregulatory Circuits

Read more
September 16, 2022

Preprint “Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ regulatory T cells” is online at JCI

A study led by Janine Becker-Gotot and Christian Kurts from the IMMEI and Johannes Oldenburg from…
Read more
August 24, 2022

IMMEI study identifies cellular and molecular mechanisms promoting severe ANCA vasculitis progression

Read more
Using this content requires loading third-party content from Twitter. In doing so, data is transmitted to third parties in accordance with our data protection policy. By clicking on Activate content, you agree to Twitter's data protection policy.